The Pneumococcal Awareness Council of Experts (PACE), a project of Sabin launched in 2006, focuses on pneumococcal disease awareness and prevention, and works through a variety of mediums to drive forward pneumococcal awareness and advocacy efforts. Working with more than 100 professional medical societies around the globe, PACE informs policymakers about the global threat of pneumococcal disease and works to secure commitments from countries to combat the disease.
In addition to leading various pneumococcal research studies, Sabin convenes the world’s leading experts in epidemiology and other key public health professionals at regional and country-level symposia each year. Developed in collaboration with the Pan American Health Organization (PAHO), the U.S. Centers for Disease Control and Prevention (CDC) and PneumoADIP, the regional symposia provide a forum to share the latest pneumococcal research and new prevention strategies.
Rotavirus is the most common cause of diarrheal hospitalizations and deaths among children worldwide, killing more than 200,000 children under five each year. Two vaccines were recently introduced to the market, but their introduction in countries lags, as does awareness of the true burden of the disease. Since 2004, Sabin, in collaboration with various rotavirus stakeholders, has organized the International Rotavirus Symposium series to bring together scientists, policy makers and other key stakeholders in order to share knowledge and raise the profile of this deadly disease.
Pneumococcal disease is a deadly infectious disease that kills 1.6 million people each year, including 800,000 children under age five. Global awareness of this deadly disease, however, remains low. Sabin convenes the world’s leading experts in epidemiology and other key public health professionals at regional and country-level symposia, including the Regional Pneumococcal Symposium. Developed in collaboration with the World Health Organization (WHO), the Pan American Health Organization (PAHO), the U.S.
In recent years mass vaccination campaigns in Latin America have resulted in significant progress in improving health throughout the region, including the eradication and elimination of polio, measles and rubella in the Americas. Many countries are looking to expand vaccination coverage and introduce new vaccines, such as those against hepatitis B, Haemophilus Influenzae type b (Hib), rotavirus, human papilloma virus (HPV) and pneumococcal disease. But as more vaccines become available, it becomes increasingly important to understand the current guidelines and recommendations re
The Advisory Committee on Immunization Practices (ACIP) is a group of 15 immunization experts who assist in determining vaccination recommendations for the United States. Based on their own knowledge, as well as research results, committee recommendations, cost-effective analyses and a range of other information, the ACIP recommends which vaccines should be used, which populations should be vaccinated, and how frequently the vaccinations should be administered